ES456999A1 - Procedimiento de preparacion de nuevas lactonas derivadas del ciclopentanol. - Google Patents

Procedimiento de preparacion de nuevas lactonas derivadas del ciclopentanol.

Info

Publication number
ES456999A1
ES456999A1 ES456999A ES456999A ES456999A1 ES 456999 A1 ES456999 A1 ES 456999A1 ES 456999 A ES456999 A ES 456999A ES 456999 A ES456999 A ES 456999A ES 456999 A1 ES456999 A1 ES 456999A1
Authority
ES
Spain
Prior art keywords
group
those
compounds
formula
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES456999A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES456999A1 publication Critical patent/ES456999A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES456999A 1976-03-19 1977-03-18 Procedimiento de preparacion de nuevas lactonas derivadas del ciclopentanol. Expired ES456999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7608004A FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ES456999A1 true ES456999A1 (es) 1978-01-16

Family

ID=9170682

Family Applications (1)

Application Number Title Priority Date Filing Date
ES456999A Expired ES456999A1 (es) 1976-03-19 1977-03-18 Procedimiento de preparacion de nuevas lactonas derivadas del ciclopentanol.

Country Status (20)

Country Link
JP (1) JPS52113956A (fr)
AT (1) AT357275B (fr)
AU (1) AU506760B2 (fr)
BE (1) BE852624A (fr)
CA (1) CA1094569A (fr)
CH (1) CH620688A5 (fr)
DE (1) DE2711950A1 (fr)
DK (1) DK119377A (fr)
ES (1) ES456999A1 (fr)
FR (1) FR2344285A1 (fr)
GB (1) GB1538717A (fr)
HU (1) HU178332B (fr)
IE (1) IE45124B1 (fr)
IL (1) IL51690A (fr)
LU (1) LU76976A1 (fr)
NL (1) NL7703056A (fr)
PT (1) PT66326B (fr)
SE (1) SE436877B (fr)
SU (2) SU749364A3 (fr)
ZA (1) ZA771654B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439779A2 (fr) * 1976-03-19 1980-05-23 Roussel Uclaf Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
FR2443466A1 (fr) * 1978-12-05 1980-07-04 Roussel Uclaf Nouvelles b-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leur procede de preparation et leur application comme medicaments
DE3722133A1 (de) * 1987-07-04 1989-01-12 Bayer Ag Azolyl-tetrahydropyran-derivate
EP1142886A1 (fr) * 2000-04-07 2001-10-10 Aventis Pharma Deutschland GmbH Percyquinine, procédé pour sa production et son utilisation comme produit pharmaceutique
CN100417650C (zh) * 2006-08-17 2008-09-10 中国科学院昆明植物研究所 韧革菌素及其制备方法和在药物上的应用
WO2011013651A1 (fr) * 2009-07-28 2011-02-03 小野薬品工業株式会社 Composé bicyclique et utilisation de celui-ci à des fins médicales

Also Published As

Publication number Publication date
SE7702908L (sv) 1977-09-20
AT357275B (de) 1980-06-25
IL51690A0 (en) 1977-05-31
AU2346677A (en) 1978-09-28
BE852624A (fr) 1977-09-19
DE2711950A1 (de) 1977-09-29
IL51690A (en) 1982-02-28
GB1538717A (en) 1979-01-24
SE436877B (sv) 1985-01-28
AU506760B2 (en) 1980-01-24
ZA771654B (en) 1978-04-26
FR2344285A1 (fr) 1977-10-14
IE45124L (en) 1977-09-19
HU178332B (en) 1982-04-28
PT66326B (pt) 1979-01-18
FR2344285B1 (fr) 1979-02-02
ATA195077A (de) 1979-11-15
SU745366A3 (ru) 1980-06-30
JPS52113956A (en) 1977-09-24
LU76976A1 (fr) 1977-10-03
IE45124B1 (en) 1982-06-30
JPS62146B2 (fr) 1987-01-06
DK119377A (da) 1977-09-20
CA1094569A (fr) 1981-01-27
CH620688A5 (en) 1980-12-15
PT66326A (fr) 1977-04-01
SU749364A3 (ru) 1980-07-15
NL7703056A (nl) 1977-09-21

Similar Documents

Publication Publication Date Title
EP0014720A4 (fr) Tensiometre.
ES432106A1 (es) Procedimiento para la preparacion de d-homo-20-cetopregna- nos.
ES456999A1 (es) Procedimiento de preparacion de nuevas lactonas derivadas del ciclopentanol.
GB1424416A (en) Prostaglandin intermediates and their preparation
GB1363472A (en) 17-chlorosteroids
JPS559024A (en) Tetrahydro ml-236b, its derivative, and remedy for hyperlipemia comprising it as active constituent
ES473534A1 (es) Procedimiento para la preparacion de analogos de prostaci- clina
IE38659L (en) Pregnane acid derivatives.
GB1427910A (en) Method of preparing a methacrylic acid ester
Kakisawa et al. The stereochemistry of the grayanotoxins
GB1308849A (en) Process for the preparation of 6alpha-methyl-19-nor-pregnenes
SE7510466L (sv) Prostansyraderivat
GB1330520A (en) Polymers of thio-substituted compounds
GB1307227A (en) Pharmaceutical compositions comprising dicarboxylic acids and their derivatives
IE41407L (en) Prostanoic acid analogues
GB1205159A (en) Process for the production of lactones
GB1380555A (en) Process for the preparation of 2,3,5-trimethylhydroquinone
CH609024A5 (en) Process for the preparation of new sulphur-containing diaryl and oxygen-containing diaryl compounds
JPS52111587A (en) Preparation of 6-aminopenam carboxylic acid-1-oxide or its derivatives
IE45460L (en) Propanediol derivative.
ES434548A1 (es) Procedimiento para preparar esteres de diglicidilo de aci- dos dicarboxilicos cicloalifaticos.
ES433554A1 (es) Un procedimiento para la produccion de nuevos compuestos deacido xantona-2-carboxilicos 5-7-disustituidos.
JPS5432473A (en) Antibiotics pseudomonic acid derivative and its preparation
JPS53130618A (en) Preparation of 2,4,6,8 tetramethyldecanoic acid or its ester
JPS5371016A (en) Preparation of glycolic acid and/or diglycolic esters